(Q54523252)

30 May 2018

title

Discovery of potent HDAC inhibitors based on chlamydocin with inhibitory effects on cell migration. (English)

1 reference

30 May 2018

author name string

Shimiao Wang

1

1 reference

30 May 2018

Xiaohui Li

2

1 reference

30 May 2018

Yingdong Wei

3

1 reference

30 May 2018

Zhilong Xiu

4

1 reference

30 May 2018

Norikazu Nishino

5

1 reference

30 May 2018

publication date

27 November 2013

1 reference

30 May 2018

published in

ChemMedChem

1 reference

30 May 2018

volume

9

1 reference

30 May 2018

issue

3

1 reference

30 May 2018

page(s)

627-637

1 reference

30 May 2018

Regulation of histone deacetylase activities

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

The language of histone crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylase inhibitors: molecular mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Lysine acetylation targets protein complexes and co-regulates major cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Substrate and functional diversity of lysine acetylation revealed by a proteomics survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylase inhibitors: overview and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Clonogenic assay of cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Mechanisms of G1 cell cycle arrest and apoptosis in myeloma cells induced by hybrid-compound histone deacetylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Chlamydocin-hydroxamic acid analogues as histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Chemical origins of isoform selectivity in histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylases (HDACs): characterization of the classical HDAC family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Synthesis, evaluation and molecular modeling of cyclic tetrapeptide histone deacetylase inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: Potent inhibition of histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone Deacetylase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

HDAC inhibitors: clinical update and mechanism-based potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

A novel class of small molecule inhibitors of HDAC6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Epigenomics of leukemia: from mechanisms to therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Regulation of the G1 phase of the mammalian cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Ceramide inhibition of MMP-2 expression and human cancer bronchial cell invasiveness involve decreased histone acetylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Matrix metalloproteinases: regulators of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Comparative analysis of the role of small G proteins in cell migration and cell death: cytoprotective and promigratory effects of RalA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Specific activity of class II histone deacetylases in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

The regulation of matrix metalloproteinases and their inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Highly Potent and Selective Histone Deacetylase 6 Inhibitors Designed Based on a Small-Molecular Substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

An overview of the cell cycle arrest protein, p21(WAF1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

inferred from DOI database lookup

7 January 2021

based on heuristic

Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201300372

1 reference

30 May 2018

PubMed ID

24285590

1 reference

30 May 2018